New insider activity at Regeneron ( (REGN) ) has taken place on October 31, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Christine Poon recently made a significant move by selling 6,500 shares of Regeneron stock, amounting to a total transaction value of $4,252,745.
Recent Updates on REGN stock
Regeneron Pharmaceuticals has been in the spotlight due to several recent developments impacting its stock. The company announced the initiation of a pivotal Phase 3 clinical study for linvoseltamab in treating relapsed/refractory multiple myeloma, which could enhance its competitive position if successful. Additionally, the completion of a real-world evidence study on aflibercept provided important safety data, potentially boosting investor confidence in its ophthalmology products. However, Regeneron faces risks from tariffs and trade restrictions that could affect its supply chain and financial health. The company’s Q3 earnings report showed a 1% revenue increase, driven by strong sales of Dupixent and new FDA approvals, despite some operational challenges like affordability issues with EYLEA and FDA setbacks. Overall, Regeneron’s financial strength and strategic advancements in its R&D pipeline have contributed to a positive market sentiment, although external risks and operational hurdles remain concerns.
Spark’s Take on REGN Stock
According to Spark, TipRanks’ AI Analyst, REGN is a Outperform.
Regeneron’s strong financial performance and robust earnings call results are the primary drivers of its stock score. The company’s solid balance sheet and cash flow position support its growth prospects. Technical indicators suggest bullish momentum, though caution is advised due to potential overbought conditions. Valuation metrics indicate the stock is fairly valued within its sector.
To see Spark’s full report on REGN stock, click here.
More about Regeneron
YTD Price Performance: -7.79%
Average Trading Volume: 1,072,092
Technical Sentiment Signal: Buy
Current Market Cap: $68.73B